Skip to main navigation Skip to search Skip to main content

Insulin signalling regulates Pink1 mRNA localization via modulation of AMPK activity to support PINK1 function in neurons

  • J. Tabitha Hees
  • , Simone Wanderoy
  • , Jana Lindner
  • , Marlena Helms
  • , Hariharan Murali Mahadevan
  • , Angelika B. Harbauer

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

Mitochondrial quality control failure is frequently observed in neurodegenerative diseases. The detection of damaged mitochondria by stabilization of PTEN-induced kinase 1 (PINK1) requires transport of Pink1 messenger RNA (mRNA) by tethering it to the mitochondrial surface. Here, we report that inhibition of AMP-activated protein kinase (AMPK) by activation of the insulin signalling cascade prevents Pink1 mRNA binding to mitochondria. Mechanistically, AMPK phosphorylates the RNA anchor complex subunit SYNJ2BP within its PDZ domain, a phosphorylation site that is necessary for its interaction with the RNA-binding protein SYNJ2. Notably, loss of mitochondrial Pink1 mRNA association upon insulin addition is required for PINK1 protein activation and its function as a ubiquitin kinase in the mitophagy pathway, thus placing PINK1 function under metabolic control. Induction of insulin resistance in vitro by the key genetic Alzheimer risk factor apolipoprotein E4 retains Pink1 mRNA at the mitochondria and prevents proper PINK1 activity, especially in neurites. Our results thus identify a metabolic switch controlling Pink1 mRNA localization and PINK1 activity via insulin and AMPK signalling in neurons and propose a mechanistic connection between insulin resistance and mitochondrial dysfunction.
Original languageEnglish
Pages (from-to)514-530
JournalNature Metabolism
Volume6
Issue number3
DOIs
Publication statusPublished - 1 Mar 2024
Externally publishedYes

Funding

We thank C. Weiß and A. Schneider for technical support and the members of the Harbauer laboratory for their support and many fruitful discussions. We are grateful to R. Kasper, E. Laurell, C. Polisseni (Imaging facility, Max Planck Institute for Biological Intelligence) and M. Spitaler and M. Oster (Imaging facility, Max Planck Institute of Biochemistry) for assistance with live-cell imaging. We also thank S. Suppmann from the Protein Purification Core and B. Steigenberger from the Mass Spectrometry Facility for their assistance with protein purification and phospho-proteomics. Furthermore, we thank the International Max Planck Research School for Biological Intelligence (IMPRS-BI), of which J.T.H., M.H. and H.M.M. are part. A.B.H. is supported by the Max Planck Society (MPRGL Harbauer) and the Deutsche Forschungsgemeinschaft (German Research Council, HA 7728/2-1, ID 453679203, and TRR353, ID 471011418) and under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy, ID 390857198), as well as by the European Union (ERC StG Project 101077138, MitoPIP). Views and opinions expressed are those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for the views expressed.

FundersFunder number
Max-Planck-Gesellschaft
European Commission
Deutsche Forschungsgemeinschaft471011418, 390857198, 453679203, TRR353, HA 7728/2-1
European Research Council101077138

    Fingerprint

    Dive into the research topics of 'Insulin signalling regulates Pink1 mRNA localization via modulation of AMPK activity to support PINK1 function in neurons'. Together they form a unique fingerprint.

    Cite this